Atlas Pharmaceuticals

Atlas Pharmaceuticals is a specialized pharmaceutical company focused on developing and providing innovative medications for the veterinary industry, enhancing healthcare solutions for animal practices. Founded in 2017, Atlas Pharmaceuticals is based in Phoenix, US, and specializes in veterinary pharmaceuticals. The company was acquired in August 2017 by Vets First Choice, which is part of a broader investment portfolio. The founder, Carmen Vigo, has a background in the pharmaceutical industry, contributing to the company’s strategic direction.

Atlas Pharmaceuticals offers a range of pharmaceutical products tailored for veterinary practices, focusing on both small and large animal care. Their offerings include medications, nutritional products, and technology solutions that help streamline operations in veterinary clinics. This diverse product suite aims to enhance patient care and ensure compliance with regulatory standards, serving veterinary practices and hospitals across North America, Europe, and the Asia-Pacific regions. The company generates revenue through direct sales to veterinary practices and partnerships with animal health professionals.

This includes product sales and subscription services for their technology solutions. Their pricing strategy is designed to be competitive, accommodating clinics of varying sizes, with options for monthly subscriptions and on-demand purchases of pharmaceuticals and nutritional products. Looking ahead, Atlas Pharmaceuticals plans to launch new veterinary products designed to address emerging health needs in the animal care sector. The company is also targeting expansion into new markets, particularly in Europe and Asia, by 2025.

Recent funding from the acquisition in August 2017 will support these growth initiatives, allowing Atlas to enhance its product development and market reach.